While low-risk patients who undergo elective surgery can tolerate low hematocrit levels, the benefits of higher hematocrit levels might outweigh the risk of transfusion in high-risk patients.
The new findings of the last years may show the techniques to new innovative therapies and could probably play an important role in treating CHD in the future.